BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 21172868)

  • 21. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.
    Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T
    Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance.
    Schulz SM; Köhler G; Holscher C; Iwakura Y; Alber G
    Int Immunol; 2008 Sep; 20(9):1129-38. PubMed ID: 18599501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
    Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
    Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis.
    Mabuchi T; Singh TP; Takekoshi T; Jia GF; Wu X; Kao MC; Weiss I; Farber JM; Hwang ST
    J Invest Dermatol; 2013 Jan; 133(1):164-71. PubMed ID: 22895364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.
    Arima K; Ohta S; Takagi A; Shiraishi H; Masuoka M; Ontsuka K; Suto H; Suzuki S; Yamamoto K; Ogawa M; Simmons O; Yamaguchi Y; Toda S; Aihara M; Conway SJ; Ikeda S; Izuhara K
    Allergol Int; 2015 Jan; 64(1):41-8. PubMed ID: 25572557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia.
    Shimoura N; Nagai H; Fujiwara S; Jimbo H; Yoshimoto T; Nishigori C
    Arch Dermatol Res; 2017 May; 309(4):315-321. PubMed ID: 28299442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.
    Ren X; Li J; Zhou X; Luo X; Huang N; Wang Y; Chen X; Wei Y
    Dermatology; 2009; 219(3):232-8. PubMed ID: 19729876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
    J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation.
    Hirai T; Kanda T; Sato K; Takaishi M; Nakajima K; Yamamoto M; Kamijima R; Digiovanni J; Sano S
    J Immunol; 2013 May; 190(9):4805-11. PubMed ID: 23543761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis.
    Jiang W; Zhu FG; Bhagat L; Yu D; Tang JX; Kandimalla ER; La Monica N; Agrawal S
    J Invest Dermatol; 2013 Jul; 133(7):1777-84. PubMed ID: 23370539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.
    Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y
    J Immunol; 2010 Aug; 185(3):1887-93. PubMed ID: 20610641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of IL-17 in psoriasis.
    Malakouti M; Brown GE; Wang E; Koo J; Levin EC
    J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia.
    Lee WY; Lockniskar MF; Fischer SM
    FASEB J; 1994 Oct; 8(13):1081-7. PubMed ID: 7926375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis.
    Lo YH; Li CS; Chen HL; Chiang CY; Huang CC; Tu TJ; Lo TH; Choy DF; Arron JR; Chen HY; Liu FT
    J Invest Dermatol; 2021 Mar; 141(3):503-511.e9. PubMed ID: 32805218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of IL-17A in the development of colitis-associated cancer.
    Hyun YS; Han DS; Lee AR; Eun CS; Youn J; Kim HY
    Carcinogenesis; 2012 Apr; 33(4):931-6. PubMed ID: 22354874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
    Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity.
    Lipovsky A; Slivka PF; Su Z; Wang Y; Paulsboe S; Wetter J; Namovic MT; Gauvin D; Perron D; Gauld SB; McGaraughty S; Goedken ER
    J Invest Dermatol; 2021 Jul; 141(7):1772-1779.e6. PubMed ID: 33548244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
    Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W
    J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.